Selected to pitch in Dublin at MedTech Innovator

We are delighted that The Flume Catheter Company Inc. has been chosen to participate in the MEDTECH INNOVATOR INTERNATIONAL PITCH EVENT, and CEO Roger Holmes will present in Dublin, Ireland later this month!

MedTech Innovator is one of the largest and highest-performing accelerators of medical technology in the world and a premiere showcase for innovative medical device, digital health and diagnostic companies.

Each year, MedTech Innovator recognizes 50+ best-in-class startups and scale-ups across the medtech industry. Companies selected for this honor receive a slot in the MedTech Innovator Showcase.

Latest FLUME catheter ready to ship!

Our eagerly-awaited market expansion is underway! Product is arriving in our U.S. warehouse, and initial units will be ready to ship in early April.

Much has happened recently at the FLUME Catheter Company! In addition to having FDA 510(k) clearance for both the urethral and suprapubic indications:

  • We've transitioned manufacturing to one of the largest urinary catheter manufacturers in the world.

  • We’ve incorporated patient and clinician feedback into our forthcoming supply of catheters, which now features a 10 ml fill balloon of our innovative design.

  • We are licensed to sell in 49 U.S. states & D.C., with the last state to follow shortly.

  • The FLUME® catheter is covered under Medicare Part B.

  • Our third-party logistics partner is set to ship product, and we are continuing to establish additional distribution channels.

If you are a physician interested in learning more or ordering a special introductory box of catheters, please contact us at info@flumecatheter.com. If you are a patient, ask your urologist if you might be a good candidate for the FLUME catheter.

FLUME catheter successfully raises £1.4m Angel III funding round

The Flume Catheter Company has successfully completed its third Angel funding round, raising £1.4m. This will be used to complete the transfer of productions to a world scale catheter manufacturer and to release the latest version of FLUME catheter to a significant group of U.S. clinicians. It will support the business through to the key milestone of initial commercial sales and the basis for further funding to accelerate growth.

New VP Engineering overseeing strategic manufacturing transfer

Kristian Olsen has joined as VP Engineering. Kristian has worked with us since 2019 as the senior project engineer at Biomerics. He has been instrumental in the development of our current device and all the manufacturing processes. We are delighted that Kristian is coming on board and brings a wealth of experience in balloon catheter development. His first task if to oversee the transfer of current production to a leading global contract catheter manufacturer with whom we have signed a supply agreement. We are excited at the prospect of having the support of their capabilities as we look to scale up high quality and efficient production.

Research Study on Comfort of the New FLUME Catheter to Begin Recruitment

Duke Clinical Research Institute and Penn State College of Medicine Partner to Collect Patient Insight on Innovative FLUME Catheter

The Flume Catheter Company Ltd. (TFCC), a medical device company dedicated to developing an improved alternative to the Foley indwelling urinary catheter, announced the launch of a study to gather real-world data on patient experiences with the new FLUME catheter.

AUA 2023, Chicago, April 28-May 1

We are delighted to be exhibiting in the ‘Emerging Corner’ at AUA, aimed at showcasing new innovations in urology.

Come and meet us at Booth #1029

Learn more about our studies to evaluate FLUME vs Foley on

  • Patient comfort and Quality of Life

  • the incidence and costs of CAUTI and other complications.

Register for samples

The FLUME catheter is 510(k) cleared in the U.S.